Saint-Georges, Canada — Team Novo Nordisk’s David Lozano earned his second consecutive top 10 finish when he sprinted to eighth on the final stage of the Tour de Beauce.
For the first time in several days, Sunday’s Stage 5 began under sunny skies. Team Novo Nordisk was aggressive from the start line, with Javier Megias launching a solo attack on lap four of the 130-km, 12-lap hilly circuit. The 30-year-old Spaniard caught and then passed an early 10-man breakaway. Megias stayed out front for several laps before getting reeled in.
“I saw Javier come back to the peloton and he told me it was now my turn,” Lozano said. “At that point I started bridging my way up through all the little groups out on the course.”
Due to a challenging, technical course that forced more than 50 percent of the riders to withdraw from the race, there were many groups of riders getting lapped, making it difficult to know what riders were still competing and where the front of the race was located. As Lozano worked his way through the splintered peloton, a new five-man break attacked off the front.
“I reached what I thought was the front group because many of the general classification contenders were there, so I stayed with them,” he said. “When I opened up my sprint on the final climb, I realized that we weren’t the front group and that there were actually another few riders ahead of us.”
Overall race leader Tom Skujins (Hincapie Sportswear Development Cycling Team) took the stage win and held on to the overall race win. Lozano was the third rider across the line from his group, taking eighth for the day. The 25-year-old Spaniard was Team Novo Nordisk’s best-placed rider overall in 15th, 4:44 behind Skujins.
“I wish I had known there was another group ahead of me because I had the legs to bridge up to them,” he concluded. “It was a learning experience, but overall I felt good about today and it was definitely a fun day on the bike.”
The five-day Tour de Beauce was another successful race for the world’s first all-diabetes pro cycling team. In total, the team earned four top 10 finishes, starting with Martijn Verschoor barely missing the podium on the opening stage when he sprinted to fourth place. Megias finished sixth on Stage 2, the race’s queen stage up Mont-Megantic, and Lozano earned his first of two top 10 finishes when he took 10th on Stage 4.
Team Novo Nordisk resumes racing on June 21st in Wisconsin for the Tour of America’s Dairyland.